![](https://www.marketscreener.com/images/twitter_MS_fdnoir.png)
Luye Pharma : Announces U.S. FDA Approval of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension ...
PRINCETON, N.J., July 28, 2024 - Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sales of innovative medications, today announced that the U.S. Food and Drug Administration (FDA) has …